Renishaw plc (RSW.L) Bundle
A Brief History of Renishaw plc
Renishaw plc, founded in 1973 by Sir David McMurtry and John Deer, has evolved into a leading engineering company specializing in precision measurement and healthcare technologies. Initially, the company focused on the design and manufacture of a stylus for coordinate measuring machines (CMMs). By the early 1980s, Renishaw had launched its first product, the Rengage probe, which significantly enhanced the precision of machining processes.
Over the years, Renishaw expanded its product offerings and introduced innovations such as the REVO 5-axis measurement system in 2008. This system revolutionized the measurement capabilities for CMMs, improving efficiency and reducing measurement times.
Technological advancements continued with the introduction of the Additive Manufacturing (AM) division in 2013. Renishaw's metal 3D printing systems have gained traction within various industries, including aerospace and medical implants, showcasing the company's commitment to innovation.
In recent years, Renishaw has maintained strong financial performance. For the fiscal year ending June 30, 2023, Renishaw reported a revenue of £682 million, reflecting a growth of **16%** compared to the previous year. The company's profit before tax was reported at £143 million, resulting in a profit margin of approximately **21%**.
Renishaw's market performance has been notable as well. As of October 2023, the company's shares were trading at approximately **£38.50**, which represents a **12%** increase year-to-date. The company has also been proactive in returning value to its shareholders, with a dividend yield of **3.2%** as of the latest report.
| Year | Revenue (£ million) | Profit Before Tax (£ million) | Profit Margin (%) | Dividend Yield (%) | Stock Price (£) |
|---|---|---|---|---|---|
| 2019 | 568 | 118 | 20.8 | 3.5 | 32.00 |
| 2020 | 651 | 133 | 20.4 | 3.4 | 34.50 |
| 2021 | 618 | 129 | 20.9 | 3.0 | 30.00 |
| 2022 | 588 | 110 | 18.7 | 2.9 | 29.50 |
| 2023 | 682 | 143 | 20.9 | 3.2 | 38.50 |
The company continues to focus on research and development, investing approximately **12%** of its revenue back into innovation. This has solidified Renishaw's position as a key player in the precision engineering and additive manufacturing sectors.
With a global presence, Renishaw operates in over **35** countries and employs approximately **5,000** people worldwide. The company remains committed to sustainability and reducing its environmental footprint as part of its long-term strategy, reflecting the evolving priorities of investors and customers alike.
A Who Owns Renishaw plc
Renishaw plc, a renowned engineering and manufacturing company specializing in precision measurement and healthcare, is publicly traded on the London Stock Exchange under the ticker symbol RSW. The ownership of Renishaw is distributed among various institutional investors, individual shareholders, and company insiders.
| Shareholder Type | Percentage Ownership | Number of Shares |
|---|---|---|
| Institutional Investors | 73.6% | 18,880,847 |
| Individual Shareholders | 16.5% | 4,232,345 |
| Company Insiders | 9.9% | 2,511,654 |
As of the latest data from September 2023, the largest institutional shareholders include:
| Institution | Percentage Ownership | Number of Shares |
|---|---|---|
| BlackRock, Inc. | 9.6% | 2,450,000 |
| Schroders plc | 7.1% | 1,810,000 |
| Aberdeen Standard Investments | 5.5% | 1,400,000 |
| Invesco Ltd. | 4.3% | 1,098,000 |
| Fidelity Investments | 3.1% | 800,000 |
The founding family, the Renishaw family, plays a notable role in the ownership structure. The family maintains a significant stake, with executive directors holding a notable number of shares. The CEO, William Lee, holds approximately 2.1% of the total shares outstanding.
As of the fiscal year ending June 2023, Renishaw reported a market capitalization of approximately £3.25 billion and a revenue of £661.5 million. This financial robust performance ensures continued interest from both institutional and individual investors.
Ownership dynamics are subject to change, as investors reassess their portfolios. Trends in shareholding indicate a growing interest from institutional investors, underscoring confidence in Renishaw's market position and future growth prospects.
Renishaw plc Mission Statement
Renishaw plc, a global leader in engineering and manufacturing, emphasizes a clear mission statement that guides its operations and strategic direction. Their mission is focused on delivering innovative solutions in the field of measurement and healthcare, thereby enhancing productivity and improving quality across various industries.
Renishaw aims to provide high-quality products and services that meet precise customer requirements. The company operates under the principle of "Innovation, Quality, and Integrity," aiming to be a trusted partner for businesses requiring advanced measurement and healthcare solutions.
As of the most recent financial year, Renishaw reported significant metrics that underline its commitment to excellence. In the fiscal year ending June 2023, the company achieved the following:
| Financial Metric | Amount (£ million) |
|---|---|
| Revenue | 602.9 |
| Operating Profit | 141.6 |
| Net Profit | 118.2 |
| EPS (Earnings Per Share) | 118.9 |
| Dividends Declared | 42.0 |
| R&D Investment | 63.1 |
Renishaw’s commitment to innovation is further supported by its substantial investment in research and development, accounting for approximately 10.5% of its total revenue, which exemplifies the company's focus on advancing technology within measurement and healthcare sectors.
The geographic diversification of Renishaw's sales reflects its mission of enhancing productivity globally. The revenue breakdown for the fiscal year 2023 is as follows:
| Region | Revenue (£ million) |
|---|---|
| Europe | 345.6 |
| Asia | 192.4 |
| Americas | 64.9 |
Renishaw also places a strong emphasis on sustainability and ethical practices in line with its mission. In 2022, Renishaw achieved a reduction in carbon emissions by 12% compared to the previous year, further demonstrating its commitment to responsible business practices.
Furthermore, the company has continued to enhance its product offerings. Innovative products launched include the new generation of metal additive manufacturing systems, which have seen increased adoption across industries due to their efficiency and precision. This aligns with the company's mission of offering cutting-edge technology to improve industrial processes.
In summary, Renishaw's mission statement is intricately tied to its operational success and strategic investments in quality, innovation, and responsible practices. The company continues to drive growth in its sectors while enhancing quality and productivity for its clients around the globe.
How Renishaw plc Works
Renishaw plc, listed on the London Stock Exchange under the ticker symbol RSW, specializes in the field of precision measurement and healthcare technologies. Founded in 1973, the company operates in multiple sectors, primarily focusing on metrology and healthcare. Its innovative approach has positioned it as a leader in high-precision measurement and analysis tools.
The company's metrology segment encompasses a range of products, including coordinate measuring machines (CMMs), laser measurement systems, and precision probes. Renishaw's products are aimed at improving manufacturing efficiency and product quality across various industries such as aerospace, automotive, and energy.
In the healthcare domain, Renishaw has developed cutting-edge solutions including neurosurgical robotics and dental products. The neurosurgery system provides enhanced precision for brain surgery, while the dental technologies include 3D printing and digital scanning solutions. These advancements have positioned Renishaw favorably within the rapidly evolving healthcare technology market.
| Year | Total Revenue (£ million) | Metrology Revenue (£ million) | Healthcare Revenue (£ million) | Operating Profit (£ million) | Net Profit (£ million) |
|---|---|---|---|---|---|
| 2022 | 642.2 | 556.0 | 86.2 | 160.0 | 132.0 |
| 2021 | 501.3 | 449.0 | 52.3 | 106.0 | 89.0 |
| 2020 | 475.1 | 430.0 | 45.1 | 82.0 | 66.0 |
In terms of global reach, Renishaw has established a significant international presence, with sales offices and subsidiaries across the Americas, Europe, and Asia Pacific. As of 2022, approximately 90% of the company's revenue was generated through exports, underscoring its global operational strategy.
Renishaw’s commitment to research and development (R&D) is another vital aspect of its operations. The company invests heavily in R&D to foster innovation, with R&D spending projected at about 13% of total revenue in the fiscal year 2022. This investment has led to numerous patents and ongoing advancements in technology, which ensure that Renishaw stays ahead of industry trends.
The company’s financial health showcases resilience and stability. As of September 2022, the cash and cash equivalents stood at approximately £185.0 million, aiding its capability to invest in growth opportunities and navigate market fluctuations. The operational efficiency is evident in the operating margin, which has consistently remained around 25%.
Renishaw's business model operates on a blend of direct sales and strategic partnerships with distributors worldwide. The company also engages in providing training and after-sales support, which enhances customer satisfaction and loyalty.
In summary, Renishaw plc operates within high-precision measurement and healthcare technology sectors, leveraging its robust R&D, global market outreach, and strong financial positioning to drive growth and innovation. This multifaceted approach ensures that the company continues to lead in its industry while adapting to the evolving technological landscape.
How Renishaw plc Makes Money
Renishaw plc, a global engineering company, operates primarily in the precision measurement and healthcare sectors. Its revenue generation is driven through diverse product lines and services, including metrology, additive manufacturing, and healthcare solutions.
Revenue Streams
Renishaw’s revenue is diversified across several key areas, including:
- Metrology Systems
- Additive Manufacturing
- Healthcare Products
Metrology Systems
The metrology segment is the largest contributor to Renishaw’s revenues. In the fiscal year 2022, it accounted for approximately 71% of total revenue.
| Product Line | Revenue Contribution (2022) | Growth Rate (%) (2021-2022) |
|---|---|---|
| Coordinate Measuring Machines | £74.2 million | 10% |
| Machine Tool Probes | £52.8 million | 12% |
| Laser Calibration | £19.6 million | 8% |
Additive Manufacturing
Renishaw’s additive manufacturing segment showed significant growth, contributing 15% to total revenues in 2022. This area focuses on metal 3D printing, which has gained traction across multiple industries.
| Product Type | Revenue (2022) | Growth Rate (%) (2021-2022) |
|---|---|---|
| Metal 3D Printers | £25.4 million | 25% |
| Materials for Additive Manufacturing | £14.5 million | 20% |
Healthcare Solutions
The healthcare division, which includes products for neurosurgery and dental applications, contributed 14% of the company's revenue in 2022. This segment is integral to Renishaw’s innovative portfolio.
| Healthcare Product | Revenue (2022) | Growth Rate (%) (2021-2022) |
|---|---|---|
| Surgical Navigation Systems | £16.3 million | 18% |
| Dental Scanners | £11.2 million | 22% |
Geographic Revenue Distribution
Renishaw operates globally, with significant revenue contributions from various regions:
| Region | Revenue (2022) | Percentage of Total Revenue (%) |
|---|---|---|
| Europe | £155.8 million | 42% |
| Asia Pacific | £138.2 million | 37% |
| Americas | £67.5 million | 18% |
Financial Performance
In FY 2022, Renishaw reported total revenues of £373.5 million, reflecting a year-on-year growth of 10%. The company’s gross profit margin remained robust at 58.7%, underscoring its operational efficiency.
Net profit for the year was reported at £79.2 million, leading to earnings per share (EPS) of £1.47, compared to £1.32 in FY 2021.
Investments in R&D
Renishaw is committed to innovation, investing approximately 11% of its total revenue back into research and development. This strategic investment supports the development of new technologies and products, ensuring future growth.
The company’s focus on technological advancement, alongside a strategic expansion into international markets, positions it favorably for continued revenue growth and market share enhancement.
Renishaw plc (RSW.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.